ProPhase Labs Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,638.00
2,926.00
1,664.00
441.00
24,438.00
8,241
Total Accounts Receivable
5,319.00
5,836.00
4,000.00
5,770.00
1,945.00
7,798
Inventories
2,521.00
3,292.00
4,331.00
2,736.00
1,531.00
1,903
Other Current Assets
1,801.00
1,404.00
1,884.00
680.00
503.00
296
Total Current Assets
11,279.00
13,458.00
11,879.00
9,627.00
28,417.00
18,238
Net Property, Plant & Equipment
2,564.00
2,599.00
2,950.00
3,175.00
2,742.00
2,499
Total Investments and Advances
-
-
-
-
2,500.00
-
Intangible Assets
3,577.00
-
-
-
-
-
Total Assets
17,420.00
16,057.00
14,829.00
12,802.00
33,659.00
20,737
ST Debt & Current Portion LT Debt
-
-
-
1,490.00
-
Accounts Payable
1,011.00
667.00
990.00
2,156.00
562.00
Other Current Liabilities
3,613.00
4,574.00
3,544.00
3,194.00
1,250.00
Total Current Liabilities
4,624.00
5,241.00
4,534.00
6,840.00
1,812.00
Long-Term Debt
-
-
1,466.00
-
-
Other Liabilities
200.00
100.00
-
-
-
Total Liabilities
4,824.00
5,341.00
6,000.00
6,840.00
1,812.00
Common Equity (Total)
12,596.00
10,716.00
8,829.00
5,962.00
31,847.00
Total Shareholders' Equity
12,596.00
10,716.00
8,829.00
5,962.00
31,847.00
Total Equity
12,596.00
10,716.00
8,829.00
5,962.00
31,847.00
Liabilities & Shareholders' Equity
17,420.00
16,057.00
14,829.00
12,802.00
33,659.00

About ProPhase Labs

View Profile
Address
621 North Shady Retreat Road
Doylestown Pennsylvania 18901
United States
Employees -
Website http://www.prophaselabs.com
Updated 07/08/2019
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products, dietary supplements, and other remedies. Its products include TK supplement and Organix Rx. The company was founded by Guy J.